bioRxiv · 10.1101/2024.03.11.584402
Targeted protein degradation of the CPSF complex by benzoxaboroles through sumoylation
Abstract
Benzoxaboroles (BoBs) feature a boron-heterocyclic core and are an important innovation in the development of drugs against a range of pathogens and other pathologies. A broad spectrum of pharmacology is associated with chemically diverse BoB derivatives and includes multiple modes-of-action (MoA) and targets. However, a consensus MoA for BoBs targeting evolutionarily diverse protozoan pathogens has emerged with the identification of CPSF3/CPSF73 in the CPSF complex in both apicomplexan and kinetoplastida parasites. Here we establish a functional connection between protein sumoylation and the boron-heterocyclic scaffold shared by all BoBs using comprehensive genetic screens in Trypanosoma brucei. There is a rapid temporal and spatial shift in global protein sumoylation following BoB exposure and members of the CPSF complex are specifically destabilised in a SUMO and proteosome-dependent manner. Finally, we find rapid decrease in bulk mRNA levels, consistent with the role of CPSF3 in mRNA maturation. We propose that a combination of direct inhibition coupled with targeted degradation of CPSF3 underpins the specificity of BoBs against trypanosomatids.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Zhang, N., Samad, A., Zahedifard, F., Wall, R. J., Horn, D., Zoltner, M., Field, M. C.. 2024-03-12. Targeted protein degradation of the CPSF complex by benzoxaboroles through sumoylation. https://doi.org/10.1101/2024.03.11.584402
Cite the original work for its findings. Save a collection to share your selection of sources.